RxDoctor Payments Data

Dora Broom, PA

Physician Assistant · Woodstock, GANPI 1144642844

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $17,591 of the $19,756 with a category attached, or 89.0%. It is spread thinly across 33 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,756in general payments, 2019–2025

Across 854 payments — averaging $23.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$2K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Johnson & Johnson$1K
  • Novartis$1K
  • LEO Pharma Inc.$1K
  • plus $11K from 27 others

What the payments were for

  • Consulting fees$1,4257%
  • Food & beverage$17,59189%
  • Education$7404%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,756 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$88,122
Medicare patients
490
Services billed
2,058

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab43$163,528
Dupixent SyringeDupilumab14$61,851
JubliaEfinaconazole13$9,269
Clobetasol Propionate97$2,464
Doxycycline Hyclate84$1,407
Mometasone Furoate63$1,015
Metronidazole23$842
Ketoconazole43$732
Betamethasone Valerate18$677
Triamcinolone Acetonide38$520
ValacyclovirValacyclovir Hcl11$432
Imiquimod19$408
Ciclopirox15$391
Nystatin28$385
Mupirocin27$242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$420$9,26913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Woodstock

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →